7941/13381US=23-D / Câncer
Wong CYO. Surgically unresectable and chemotherapy-refractory metastatic liver carcinoma: treatment with yttrium-90 microsphere follwed by assessment with positron emission tomography. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: liver cancer. New York: Springer, 2009. p. 103-14. ISBN 978-1-4020-9803-1.

AVALIACAO ATRAVES DA TOMOGRAFIA POR EMISSAO DE POSITRONS; Y-90 RADIOEMBOLIZACAO MICROESFERA; CARCINOMA DE FIGADO IRRESSECAVEL CIRURGICAMENTE; QUIMIOTERAPIA-REFRATARIO METASTATICO; TRATAMENTO COM ITRIO-90 MICROESFERA FOLLWED


7942/13381US=23-D / Câncer
Machi J. Unresectable livre metastases from colorectal cancer: methodology and prognosis with radiofrequency ablation. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: liver cancer. New York: Springer, 2009. p. 117-31. ISBN 978-1-4020-9803-1.

METODOLOGIA DA ABLACAO POR RADIOFREQUENCIA; PROGNOSTICO USANDO ABLACAO POR RADIOFREQUENCIA; ATUAL PAPEL ABLACAO DE RADIO-FREQUENCIA


7943/13381US=23-D / Câncer
Lu SN, Wang JH, Kee KM, Tseng PL. Screening with ultrasonography of patients at high-risk for hepatocellular carcinoma: thrombocytopenia as a valid surrogate of cirrhosis. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: liver cancer. New York: Springer, 2009. p. 137-44. ISBN 978-1-4020-9803-1.

EPIDEMIOLOGIA DO CARCINOMA HEPATOCELULAR; EPIDEMIOLOGIA DA CIRROSE HEPATICA; BENEFICIO DO RASTREIO HCC; CIRROSE HEPATICA. TESTES DE SUBSTITUICAO; FRIBOSIS. ESTES DE SUBSTITUICAO; RASTREIO HCC ECOGRAFICA. ADULTO TROMBOCITOPENICA


7944/13381US=23-D / Câncer
Choi BI, Kim SH. Hepatocellular carcinoma: contrast-enhanced sonography. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: liver cancer. New York: Springer, 2009. p. 145-58. ISBN 978-1-4020-9803-1.

CARCINOMA HEPATOCELULAR; CONTRASTE ULTRA-SONOGRAFIA; CONTRASTE DE COR MELHORADA DOPPLER; CONTRASTE MAIS POTENCIA DOPPLER; MELHOR CONTRASTE HARMONICO DE ENERGIA ULTRA-SONOGRAFIA DOPPLER; CONTRASTE ULTRA-SONOGRAFIA DE PULSO DE INVERSAO-ENHANCED HARMONICA


7945/13381US=23-D / Câncer
Migaleddu V, Virgilio G. Focal liver lesion: nonlinear contrast-enhanced ultrasound imaging. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: liver cancer. New York: Springer, 2009. p. 159-81. ISBN 978-1-4020-9803-1.

LESAO HEPATICA FOCAL; ULTRA-SONOGRAFIA NAO-LINEAR DE CONTRASTE; HARMONICA DE IMAGEM; FUNDO FISICA E TECNOLOGICA; ENHACEMENT CONTRASTE NAO-LINEAR DE LESOES HEPATICAS FOCAIS


7946/13381US=23-D / Câncer
Taouli B. Hepatocellular carcinoma: magnetic resonance imaging. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: liver cancer. New York: Springer, 2009. p. 183-92. ISBN 978-1-4020-9803-1.

CARCINOMA HEPATOCELULAR. RESSONANCIA MAGNETICA; APARENCIA DE RESSONANCIA MAGNETICA DO CARCINOMA HEPATOCELULAR; ACESSORIO DE GADOLINIO DE CARCINOMA HEPATOLOCELLULAR; APARENCIAS ATIPICAS DE CARCINOMA HEPATOCELULAR


7947/13381US=23-D / Câncer
Kanematsu M, Semelka RC, Osada S. Expression of hepatocellular endothelial growth factor in hepatocellular carcinoma: correlation with radiologic findings. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: liver cancer. New York: Springer, 2009. p. 193-211. ISBN 978-1-4020-9803-1.

HISTORIA DE DIAGNOSTICO RADIOLOGICO DO CARCINOMA HEPATOCELULAR; DESENVOLVIMENTO DE CARCINOMA HEPATOCELULAR


7948/13381US=23-D / Câncer
Kiryu S, Ohtomo K. Detection of small hepatic lesion: superparamagnetic oxide-enhanced diffusion-Weighted T2 FSE imaging. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: liver cancer. New York: Springer, 2009. p. 213-9. ISBN 978-1-4020-9803-1.

LESAO HEPATICA PEQUENA; SUPERPARAMAGNETICO OXIDO AVANCADA DIFUSAO PONDERADA T2 FSE IMAGEM; SPIO AVANCADA DWI T2 FSE IMAGEM USANDO HELICE


7949/13381US=23-D / Câncer
Onishi H, Murakami T, Nakumura H. Diagnosis of hepatocellular carcinoma: multidetector-row computed tomography and magnetic resonance imaging. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: liver cancer. New York: Springer, 2009. p. 221-35. ISBN 978-1-4020-9803-1.

TECNICA DE VARREDURA POR RESSONANCIA MAGNETICA; CONTRASTE DINAMICO MAIOR RESSONANCIA MAGNETICA; COMPUTADOR ANGIOTOMOGRAFIA; RESSONANCIA MAGNETICA DE CARCINOMA HEPATOCELULAR; ESTADIAMENTO DO CARCINOMA HEPATOCELULAR


7950/13381US=23-D / Câncer
Ichikawa T, Araki T. Hepatocellular carcinoma: effects of injection rate/injection duration of contrast material on computer tomography. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: liver cancer. New York: Springer, 2009. p. 237-40. ISBN 978-1-4020-9803-1.

CARCINOMA HEPATOCELULAR. EFEITOS DA DURACAO INJECAO TAXA; INJECCAO DE MATERIAL DE CONTRASTE EM TOMOGRAFIA COMPUTADORIZADA


7951/13381US=23-D / Câncer
Nishie A, Yoshimitsu K. Detection of combined hepatocellular and cholangiocarcinoma: enhanced computed tomography. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: liver cancer. New York: Springer, 2009. p. 241-60. ISBN 978-1-4020-9803-1.

DETECCAO DE COLANGIOCARCINOMA HEPATOCELULAR E COMBINADO; TOMOGRAFIA COMPUTADORIZADA


7952/13381US=23-D / Câncer
Takayasu K. Hepatocellular carcinoma and adenomatous hyperplasia (dysplastic nodules): and a combination of computer tomography and angiography. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: liver cancer. New York: Springer, 2009. p. 241-60. ISBN 978-1-4020-9803-1.

LESOES NODULARES HEPATOCELULARES; HEPATOCARCINOGENESE; AGULHA DE BIOPSIA; CARCINOMA HEPATOCELULAR AVANCO; CARCINOMA HEPATOCELULAR PRECOCE; CARCINOMA HEPATOCELULAR NODULO; HIPO-ATENUANTES LESOES NODULARES


7953/13381US=23-D / Câncer
Lodato F, Davies N, Yu D, Burroughs AK. Hepatocellular cancer in cirrhotic patients: radiological imaging. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: liver cancer. New York: Springer, 2009. p. 261-73. ISBN 978-1-4020-9803-1.

TOMOGRAFIA COMPUTADORIZADA HELICOIDAL; PROBLEMAS DE PEQUENOS NODULOS


7954/13381US=23-D / Câncer
Hsu C, Chen CN, Cheng AL. Treatment of hepatocellular carcinoma with thalidomide: assessment with power doppler ultrasound. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: liver cancer. New York: Springer, 2009. p. 277-86. ISBN 978-1-4020-9803-1.

TRATAMENTO DO CARCINOMA HEPATOCELULAR COM TALIDOMIDA; VASCULARIZACAO DO TUMOR. ULTRASSOM DOPPLER


7955/13381US=23-D / Câncer
Denecke T, Hildebrandt B, Lopez-Hänninen E. Perfusion scintigraphy with integrated single photon emission computed tomography / computed tomography in the management of transarterial treatment of hepatic malignancies. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: liver cancer. New York: Springer, 2009. p. 287-301. ISBN 978-1-4020-9803-1.

CINTILOGRAFIA DE PERFUSAO COM EMISSAO DE FOTON UNICO; TOMOGRAFIA COMPUTADORIZADA; DOENCAS MALIGNAS HEPATICAS TRANSARTERIAL. TRATAMENTO; QUIMIOTERAPIA ARTERIAL HEPATICA; RADIOEMBOLIZACAO


7956/13381US=23-D / Câncer
Sun HC. Postoperative interferon alpha treatment of patients with hepatocellular carcinoma: expression of p48 using tissue microarray. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: liver cancer. New York: Springer, 2009. p. 303-10. ISBN 978-1-4020-9803-1.

TRATAMENTO POS-OPERATORIO INTERFERON ALFA. PACIENTES COM CARCINOMA HEPATOCELULAR; P48 USANDO TISSUE MICROARRAY


7957/13381US=23-D / Câncer
Ng KTP, Man K. Hepatocellular carcinoma: overexpression of homeoprotein six 1 as a marker for predicting surgical. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: liver cancer. New York: Springer, 2009. p. 313-23. ISBN 978-1-4020-9803-1.

CARCINOMA HEPATOCELULAR


7958/13381US=23-D / Câncer
Schmid K, Mosberger I, Wrba F. Hepatocellular carcinoma: KiSS-1 overexpression as a prognostic factor. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: liver cancer. New York: Springer, 2009. p. 325-31. ISBN 978-1-4020-9803-1.

CARCINOMA HEPATOCELULAR; KISS-1 SUPEREXPRESSAO COMO FATOR PROGNOSTICO


7959/13381US=23-D / Câncer
Nakamura H, Yoshida K, Tomita Y. Hepatocellular carcinoma: prognosis using hepatoma-derived growth factor immunohistochemistry. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: liver cancer. New York: Springer, 2009. p. 333-42. ISBN 978-1-4020-9803-1.

CARCINOMA HEPATOCELULAR; HEPATOMA. FATOR DE CRESCIMENTO DERIVADO; METODOS DE IMUNO-HISTOQUIMICA; ANALITICA; HEPATOMA DERIVADO. EVOLUCAO


7960/13381US=23-D / Câncer
Kuramitsu Y, Nakamura K,. Hepatitis C virus-related human hepatocellular carcinoma: predictive markers using proteomic analysis (methodology). In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: liver cancer. New York: Springer, 2009. p. 343-50. ISBN 978-1-4020-9803-1.

VIRUS DA HEPATITE C X CARCINOMA HEPATOCELULAR HUMANO; PROTEOMICA; PROTEOMICA PARA TECIDOS DE CARCINOMA HEPATOCELULAR; PROTEOMICA PARA SOROS FROW PACIENTES COM CARCINOMA HEPATOCELULAR; PROTEOMICA PARA VIRUS DA HEPATITE C TECIDOS RELACIONADOS HEPATOCELULARES


Primeira | Anterior | Próxima | Última